UPDATE ON MYLAN LABS $MYL
This post was just published on ZYX Buy Change Alert. MYL is falling again on news of a Senator posting on her website misclassification of EpiPen for Medicaid. Even if EpiPen prices cut further, this stock is easily worth north of $48. Due to increased volatility, the best way for those